CYTAC Trademark

Trademark Overview


On Wednesday, May 15, 2024, a trademark application was filed for CYTAC with the United States Patent and Trademark Office. The USPTO has given the CYTAC trademark a serial number of 98551298. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Saturday, March 1, 2025. This trademark is owned by Solu Therapeutics, Inc.. The CYTAC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for the treatment of cancers, immunological diseases, and inflammatory diseases; molecules for use in pharmaceutical preparations, namely, biological preparations for the treatment of cancers, immunological diseases, and inflammatory diseases; molecules for use in the development of pharmaceutical preparations, namely, biological preparations for scientific research use

scientific research and development; research and development in the field of pharmaceuticals; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; scientific investigations for medical purposes; development of molecules for use by others in developing and designing pharmaceutical preparations
cytac

General Information


Serial Number98551298
Word MarkCYTAC
Filing DateWednesday, May 15, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateSaturday, March 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of cancers, immunological diseases, and inflammatory diseases; molecules for use in pharmaceutical preparations, namely, biological preparations for the treatment of cancers, immunological diseases, and inflammatory diseases; molecules for use in the development of pharmaceutical preparations, namely, biological preparations for scientific research use
Goods and Servicesscientific research and development; research and development in the field of pharmaceuticals; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; scientific investigations for medical purposes; development of molecules for use by others in developing and designing pharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 15, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSolu Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMedford, MA 02155

Trademark Events


Event DateEvent Description
Wednesday, May 15, 2024NEW APPLICATION ENTERED
Sunday, November 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 4, 2024NON-FINAL ACTION E-MAILED
Friday, November 29, 2024ASSIGNED TO EXAMINER
Wednesday, December 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 4, 2024NON-FINAL ACTION WRITTEN
Thursday, February 27, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 27, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 1, 2025TEAS/EMAIL CORRESPONDENCE ENTERED